Side-by-side comparison of AI visibility scores, market position, and capabilities
Sales readiness and training platform with scalable content creation, readiness scorecards, and certifications. Now part of the Showpad-Bigtincan revenue enablement entity under Vector Capital.
Brainshark is a sales readiness and training platform originally founded in 1999 and headquartered in Waltham, Massachusetts. The company was acquired by Bigtincan in 2021 and became part of the combined Showpad-Bigtincan revenue enablement platform following the October 2025 merger under Vector Capital. Brainshark is recognized for its scalable content creation tools, sales readiness scorecards, and structured certification workflows.\n\nBrainshark's core capabilities include video-based training content authoring (narrated slide decks and microlearning modules), formal curriculum design, readiness assessments and knowledge checks, coaching submissions where reps record practice pitches for manager review, and readiness scorecards that give sales leaders a real-time view of team certification status. The platform is particularly well-suited for large enterprise rollouts, compliance training, and onboarding programs where organizations need to certify thousands of reps on product knowledge, messaging, and process adherence.\n\nWithin the combined Showpad entity, Brainshark contributes the readiness and training layer, complementing Showpad's content management and Bigtincan's digital sales room capabilities. The combined platform creates an end-to-end revenue enablement stack from content management through training certification and buyer engagement. Brainshark's integrations include Salesforce, Microsoft SharePoint, and major SCORM-compliant LMS environments.
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.